Atomoxetine has been widely used worldwide for treating attention-deficit/hyperactivity disorder. In Japan, it has been prescribed since 2009 for children and since 2012 for adults. However, no forensic autopsy cases have been reported wherein atomoxetine was identified as the primary cause of death from acute intoxication. This report describes a case of fatal acute atomoxetine intoxication in a woman in her late 20s. Prior to her death, the patient had taken several prescribed medications…
